SCHEMBL2430173

SCHEMBL2430173

COB(OC)c1cn(-c2cccc(-c3ccccc3)c2)cc(OCc2ccccc2)c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 2/20 0.49
PTGER1 P34995 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.37
ERN1 O75460 1/20 0.36
GRM5 P41594 1/20 0.36
LIPE Q05469 1/20 0.36
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PTPN1 P18031 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HTT P42858 2/20 0.34
MAPK14 Q16539 1/20 0.34
SRC P12931 1/20 0.34
ALOX5 P09917 1/20 0.34
CTSV O60911 1/20 0.34
CTSL P07711 1/20 0.34
ADORA3 P0DMS8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14471451 0.89 COMT (0.63) COMTPTGER1MRGPRX4ERN1GRM5
SCHEMBL2469729 0.81 MAPK14 (0.43) COMTPTGER1MRGPRX4GRM5PTPN1
SCHEMBL2464097 0.76 COMT (0.58) COMTPTGER1MRGPRX4GRM5PTPN1
SCHEMBL27890117 0.74 COMT (0.40) COMTPTGER1MRGPRX4GRM5MAPT
SCHEMBL14827199 0.70 COMT (0.42) COMTMAPTMAPK1MEN1KMT2A
SCHEMBL2467412 0.70 COMT (0.61) COMTPTGER1MRGPRX4GRM5MAPT
SCHEMBL2468249 0.70 COMT (0.43) COMTPTGER1MRGPRX4GRM5MAPT
SCHEMBL2464003 0.68 COMT (0.44) COMTPTGER1GRM5MAPK14SRC
SCHEMBL2432796 0.66 COMT (1.00) COMTMAPK1HTTFAAHALDH1A1
SCHEMBL2434599 0.66 COMT (0.66) COMTPTGER1MRGPRX4GRM5SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9399651-B2 Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Merck, Sharp & Dohme Corp. (US) 2016-07-26 US disclosed
US-20150299227-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MERCK SHARP & DOHME CORP. (US) 2015-10-22 US disclosed
US-9024032-B2 Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders MERCK SHARP & DOHME CORP. (US) 2015-05-05 US disclosed
US-20130084346-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MERCK SHARP & DOHME LLC 2013-04-04 US disclosed
WO-2011109254-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299227-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS COMT, PNMT, TPMT COMT 1/4885PTGER1 1145/4885MRGPRX4 4570/4885
US-20130084346-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS COMT, PNMT, TPMT COMT 1/4885PTGER1 1145/4885MRGPRX4 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.